- Home
- BHF vs SRRK Comparison
BHF vs SRRK Comparison
Compare BHF & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHF
- SRRK
- Stock Information
- Founded
- BHF 2016
- SRRK 2012
- Country
- BHF United States
- SRRK United States
- Employees
- BHF N/A
- SRRK N/A
- Industry
- BHF Life Insurance
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BHF Finance
- SRRK Health Care
- Exchange
- BHF Nasdaq
- SRRK Nasdaq
- Market Cap
- BHF 2.7B
- SRRK 3.2B
- IPO Year
- BHF N/A
- SRRK 2018
- Fundamental
- Price
- BHF $45.68
- SRRK $31.41
- Analyst Decision
- BHF Hold
- SRRK Strong Buy
- Analyst Count
- BHF 8
- SRRK 7
- Target Price
- BHF $58.13
- SRRK $43.33
- AVG Volume (30 Days)
- BHF 782.6K
- SRRK 1.5M
- Earning Date
- BHF 08-07-2025
- SRRK 08-06-2025
- Dividend Yield
- BHF N/A
- SRRK N/A
- EPS Growth
- BHF N/A
- SRRK N/A
- EPS
- BHF 9.48
- SRRK N/A
- Revenue
- BHF $8,061,000,000.00
- SRRK N/A
- Revenue This Year
- BHF $41.89
- SRRK N/A
- Revenue Next Year
- BHF $2.98
- SRRK $2,418.66
- P/E Ratio
- BHF $4.81
- SRRK N/A
- Revenue Growth
- BHF 83.37
- SRRK N/A
- 52 Week Low
- BHF $40.00
- SRRK $6.76
- 52 Week High
- BHF $64.12
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- BHF 38.74
- SRRK 35.20
- Support Level
- BHF $43.16
- SRRK $30.99
- Resistance Level
- BHF $47.01
- SRRK $33.21
- Average True Range (ATR)
- BHF 1.47
- SRRK 1.99
- MACD
- BHF 0.16
- SRRK -0.65
- Stochastic Oscillator
- BHF 41.18
- SRRK 15.44
About BHF Brighthouse Financial Inc.
Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are Annuities, Life, Run-off and Corporate and Other. It derives a majority of the revenue from the Annuities segment which includes variable, fixed, index-linked, and income annuities. The life segment includes variable, term, universal, and whole life policies.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.